Stock Screener App

무료 - Play StoreApp Store

설치하다 설치하다

HBIO

$8.603.37%-0.30

Harvard Bioscience Inc (HBIO)

Date: O: H: L: C: Vol:

Harvard Bioscience Inc 주식(HBIO)의 최신 뉴스

Harvard Bioscience, Inc. (HBIO) Seasonal returns chart - Yahoo Finance UK

Harvard Bioscience Schedules Third Quarter 2026 Earnings Conference Call for November 10, 2026 at 8:00 AM ET - GlobeNewswire

Harvard Bioscience, Inc. Estimates – NASDAQ:HBIO - TradingView

Harvard Bioscience, Inc. (HBIO) Stock Price, News, Quote & History - Yahoo! Finance Canada

Harvard Bioscience Q3 2026 Earnings Date and Estimates - MarketBeat

Harvard Bioscience Inc. R (HBI0.MU) Q1 FY2026 earnings call transcript - Yahoo Finance

Harvard Bioscience forms advisory board. Holder reports 5.20 percent in Harvard Bioscience stock - AD HOC NEWS

Harvard Bioscience Q3 2026 Earnings Date and Estimates - MarketBeat

Harvard Bioscience creates scientific advisory board - Investing.com

Harvard Bioscience forms scientific advisory board with four members - StreetInsider

Harvard Bioscience Announces Creation Of Scientific Advisory Board - TradingView

Harvard Bioscience Announces Creation of Scientific Advisory Board - GlobeNewswire

Harvard Bioscience, Inc. Announces Creation of Scientific Advisory Board - www.marketscreener.com

Harvard Bioscience stock gained 1.92 percent on October 5, 2026 - AD HOC NEWS

Harvard Bioscience grows revenue 11.10 percent: what it means for Harvard Bioscience stock - AD HOC NEWS

North America Non-Viral Transfection Reagents Market Forecast to 2035 | Cell and Gene Therapy Demand Drives 8.5% CAGR and a USD 0.70 Billion Opportunity - GlobeNewswire Inc.

Harvard Bioscience stock holds at USD 7.92 after reverse split - AD HOC NEWS

Over 5% stake disclosed in Harvard Bioscience (HBIO) - Stock Titan

HBIO: Harvard Bioscience Inc. Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits

Harvard Bioscience stock trades steady as investors look to latest revenue trends - ad-hoc-news.de

Harvard (HBIO) Chart: Records a 0.13% Increase to $7.49; Price Context: the Price Remains Bounded by the Supplied Support and Resistance on the Day - Volatility Surface - vinanet.vn

Harvard Bioscience Insider Confidence Rewarded, Stock Hits US$32m Market Cap - Sahm

Harvard Bioscience Insider Confidence Rewarded, Stock Hits US$32m Market Cap - simplywall.st

Harvard (HBIO) Results Review: EPS Exceeds Its Estimate in the Current Update; Session Move: The Stock Gains 1.58% at the Close - Net Profit Margin - vinanet.vn

Harvard Bioscience (HBIO) Q2 2026 Earnings Call Transcript - The Globe and Mail

Harvard Bioscience (HBIO) Q2 2026 Earnings Call Transcript - AOL.ca

Benchmark raises Harvard Bioscience stock price target on revenue beat By Investing.com - Investing.com South Africa

HBIO Maintained by Benchmark -- Price Target Raised to $7.50 - GuruFocus

Benchmark raises Harvard Bioscience stock price target on revenue beat - Investing.com

Benchmark raises Harvard Bioscience stock price target on revenue beat By Investing.com - Investing.com India

Benchmark raises Harvard Bioscience stock price target on revenue beat By Investing.com - Investing.com UK

Benchmark raises Harvard Bioscience stock price target on revenue beat - Investing.com

Harvard Bioscience (NasdaqCM:HBIO) Stock Forecast & Analyst Predictions - Simply Wall Street

Harvard Bioscience, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:HBIO) 2026-08-12 - Seeking Alpha

Harvard Bioscience, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance

HARVARD BIOSCIENCE INC 2026: Revenue $22.73M, EPS ($0.64) — 10-Q Summary - TradingView

Harvard Bioscience (NASDAQ: HBIO) grows Q2 sales but faces higher debt costs - Stock Titan

Harvard Bioscience Inc (HBIO) (Q2 2026) Earnings Call Highlights - GuruFocus

HBIO Looks 66.8% Undervalued on GF Value™ Despite Profitability Challenges - GuruFocus

Harvard Bioscience Inc (HBIO) (Q2 2026) Earnings Call Highlights: Revenue Surges 11% and ... - Yahoo Finance

Harvard Bioscience Releases Q2 2026 Financial Results - AlphaStreet

Earnings call transcript: Harvard Bioscience tops Q2 2026 forecasts, raises outlook - Investing.com Nigeria

HBio Q2 2026 slides: revenue up 11%, China growth drives guidance raise - Investing.com Nigeria

Harvard Bioscience beats Q2 estimates and raises 2026 revenue guidance - Yahoo Finance

Harvard Bioscience Raises Full-Year 2026 Revenue Guidance After Strong Second-Quarter Growth - Minichart

Earnings call transcript: Harvard Bioscience tops Q2 2026 forecasts, raises outlook - Investing.com

Why is Harvard Bioscience stock gaining today? By Investing.com - Investing.com Canada

Is Harvard Bioscience Inc (HBIO) Undervalued After Q2 Earnings B - GuruFocus

Harvard Bioscience beats estimates, raises 2026 guidance By Investing.com - Investing.com South Africa

Harvard Bioscience beats estimates, raises 2026 guidance By Investing.com - Investing.com Australia

HBIO와(과) 유사한 종목

DAVI$1.4911.31%

MLSS$0.32255.88%